| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |